Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
HUMA
#3068
Humacyte, Inc. Common Stock
1.1
2
-6.67%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-6.67%
Monatliche Änderung
+7.69%
6 month change
-28.66%
Jahresänderung
-66.06%
Vorheriger Schlusskurs
1.2
0
Open
1.1
2
Bid
Ask
Low
1.1
2
High
1.1
2
Volumen
61
Märkte
Aktien
Gesundheitswesen
HUMA
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
12.86 M
103 M
103.33 M
119.08 M
155.12 M
—
Valuation ratios
Enterprise value
—
529.28 M
68.25 M
263.7 M
738.41 M
1.54 B
Price to earnings ratio
—
-10.98
-17.58
-2.7
-4.01
-18.69
Price to sales ratio
—
222.91
138.94
—
149.58 K
—
Price to cash flow ratio
—
3.57
3.06
4.08
6.1
13.08
Price to book ratio
—
2.37
1.86
22.06
11.36
16.39
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
0.09
0.06
0.86
1.08
0.86
Return on equity %
—
0.22
0.1
8.18
2.82
14.46
Return on invested capital %
—
406.93
562.3
737.13
646.28
477.43
Gross margin %
—
100
100
—
100
—
Operating margin %
—
6 246.77
5 405.75
—
2.86 M
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
2 038.46
764.54
—
3.72 M
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.02
20.75
7.88
4.52
2.4
10.15
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0.01
0.01
0
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.1
0.1
0.3
0.46
1.53
Long term debt to total equity ratio
—
0.22
0.17
2.85
1.2
23.11
Per share metrics
Operating cash flow per share
—
2.03
0.69
0.71
0.83
0.76
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
5.64
1.47
0.78
0.38
1.22
Net current asset value per share
—
5.74
1.5
0.81
0.4
1.56
Tangible book value per share
—
3.06
1.13
0.13
0.44
0.77
Working capital per share
—
5.46
1.31
0.63
0.24
0.94
Book value per share
—
3.06
1.13
0.13
0.44
0.77
Nachrichten
Humacyte, Inc. (HUMA) Falls More Steeply Than Broader Market: What Investors Need to Know
BTIG reiterates Buy rating on Humacyte stock amid DoD funding news
Humacyte-Aktie legt nach Finanzierungszusage des US-Verteidigungsministeriums kräftig zu
Humacyte stock jumps after securing DoD funding for vascular repair tech
US-Verteidigungsministerium budgetiert Mittel für biotechnologisch hergestellte Blutgefäße
DoD allocates funds for bioengineered vascular repair tech in 2026 budget
Humacyte, Inc. (HUMA) Exceeds Market Returns: Some Facts to Consider
Zulassungspläne in Israel: Benchmark reduziert Kursziel für Humacyte auf 10 Dollar
Benchmark lowers Humacyte stock price target to $10 on Israel filing plans
Is Humacyte, Inc. (HUMA) Outperforming Other Medical Stocks This Year?
Humacyte plans to seek approval for vessel product in Israel
Humacyte secures up to $77.5 million credit facility with Avenue Capital